These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18313627)

  • 1. Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy.
    Desai A; Fang JC
    Heart Fail Clin; 2008 Jan; 4(1):87-97. PubMed ID: 18313627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and heart failure: a dysfunction of systole, diastole or both?
    Yip GW; Fung JW; Tan YT; Sanderson JE
    J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
    Mentz RJ; Kelly JP; von Lueder TG; Voors AA; Lam CS; Cowie MR; Kjeldsen K; Jankowska EA; Atar D; Butler J; Fiuzat M; Zannad F; Pitt B; O'Connor CM
    J Am Coll Cardiol; 2014 Dec; 64(21):2281-93. PubMed ID: 25456761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart failure with preserved ejection fraction: Diastolic heart failure].
    Rutten FH; Cramer MJ; Paulus WJ
    Ned Tijdschr Geneeskd; 2012; 156(45):A5315. PubMed ID: 23134752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine models of diastolic dysfunction and heart failure with preserved ejection fraction.
    Horgan S; Watson C; Glezeva N; Baugh J
    J Card Fail; 2014 Dec; 20(12):984-95. PubMed ID: 25225111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes and hypertension on the heart.
    Pieske B; Wachter R
    Curr Opin Cardiol; 2008 Jul; 23(4):340-9. PubMed ID: 18520718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity cardiomyopathy: pathogenesis and pathophysiology.
    Wong C; Marwick TH
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):436-43. PubMed ID: 17653116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with preserved ejection fraction in older adults.
    Chen MA
    Am J Med; 2009 Aug; 122(8):713-23. PubMed ID: 19635270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology].
    Kuchynka P; Palecek T; Simek S; Lubanda JC; Elleder M; Spicka I; Jansa P; Linhart A
    Vnitr Lek; 2008 Oct; 54(10):1010-3. PubMed ID: 19009770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations.
    Giles TD; Sander GE
    Cardiol Clin; 2004 Nov; 22(4):553-68. PubMed ID: 15501623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity on the risk of heart failure and its prognosis.
    Artham SM; Lavie CJ; Patel HM; Ventura HO
    J Cardiometab Syndr; 2008; 3(3):155-61. PubMed ID: 18983332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the treatment of heart failure with a preserved ejection fraction.
    Das A; Abraham S; Deswal A
    Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breathing disorders during sleep: current developments].
    Gugger M
    Schweiz Med Wochenschr; 1997 Feb; 127(6):204-7. PubMed ID: 9157525
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular bases of heart failure].
    Rodríguez Pérez JM; Gallardo GJ; Vargas Alarcón G
    Arch Cardiol Mex; 2006; 76 Suppl 4():S10-7. PubMed ID: 17469331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.
    Shinde AA; Anderson AS
    Heart Fail Clin; 2008 Oct; 4(4):479-503. PubMed ID: 18760759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and congestive heart failure: physiopathology and treatment].
    De Flines J; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1893-6, 1898-900. PubMed ID: 16972538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding of heart failure with preserved ejection fraction.
    Desai A
    Curr Opin Cardiol; 2007 Nov; 22(6):578-85. PubMed ID: 17921747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.